Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites
Open Access
- 21 February 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2), e31925
- https://doi.org/10.1371/journal.pone.0031925
Abstract
Papaya mosaic virus has been shown to be an efficient adjuvant and vaccine platform in the design and improvement of innovative flu vaccines. So far, all fusions based on the PapMV platform have been located at the C-terminus of the PapMV coat protein. Considering that some epitopes might interfere with the self-assembly of PapMV CP when fused at the C-terminus, we evaluated other possible sites of fusion using the influenza HA11 peptide antigen. Two out of the six new fusion sites tested led to the production of recombinant proteins capable of self assembly into PapMV nanoparticles; the two functional sites are located after amino acids 12 and 187. Immunoprecipitation of each of the successful fusions demonstrated that the HA11 epitope was located at the surface of the nanoparticles. The stability and immunogenicity of the PapMV-HA11 nanoparticles were evaluated, and we could show that there is a direct correlation between the stability of the nanoparticles at 37°C (mammalian body temperature) and the ability of the nanoparticles to trigger an efficient immune response directed towards the HA11 epitope. This strong correlation between nanoparticle stability and immunogenicity in animals suggests that the stability of any nanoparticle harbouring the fusion of a new peptide should be an important criterion in the design of a new vaccine.This publication has 19 references indexed in Scilit:
- Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV NanoparticlesPLOS ONE, 2011
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platformVaccine, 2008
- Translating innate response into long‐lasting antibody response by the intrinsic antigen‐adjuvant properties of papaya mosaic virusImmunology, 2008
- Novel Plant Virus-Based Vaccine Induces Protective Cytotoxic T-Lymphocyte-Mediated Antiviral Immunity through Dendritic Cell MaturationJournal of Virology, 2008
- Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopesBMC Biotechnology, 2007
- High avidity binding of engineered papaya mosaic virus virus-like particles to resting spores of Plasmodiophora BrassicaeJournal of Biotechnology, 2007
- Proteasome-Independent Major Histocompatibility Complex Class I Cross-Presentation Mediated by Papaya Mosaic Virus-Like Particles Leads to Expansion of Specific Human T CellsJournal of Virology, 2007
- Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat proteinThe FEBS Journal, 2005
- Expression of multiple foreign epitopes presented as synthetic antigens on the surface of Potato virus X particlesArchiv für die gesamte Virusforschung, 2004
- Nucleotide Sequence of Papaya Mosaic Virus RNAJournal of General Virology, 1989